Abstract

Rictor upregulation and mTORC complex 2 (mTORC2) over-activation participate in glioma cell progression, yet the underling mechanisms are not known. We here identified microRNA-153 (miR-153) as a potential anti-Rictor miRNA, which was downregulated in multiple human glioma tissues and glioma cell lines (U87MG, T98G, U373MG and U251MG). miR-153 downregulation was correlated with Rictor (mRNA and protein) upregulation and p-Akt Ser473 (the mTORC2 indicator) over-activation in the glioma tissues and cells. Our in vitro evidences suggested that Rictor could be one primary target of miR-153 in glioma cells. Exogenous overexpression of miR-153 downregulated Rictor (mRNA and protein) and decreased p-Akt Ser473 in U87MG cells, leading to significant growth inhibition and apoptosis activation. Notably, U87MG cells with Rictor shRNA knockdown showed similar phenotypes of cells with miR-153 overexpression. More importantly, in Rictor-silenced U87MG cells, miR-153 expression failed to further affect cell growth nor apoptosis. In vivo, we showed that miR-153 overexpression dramatically inhibited U87MG tumor growth in nude mice. Together, these results suggest that miR-153 downregulation could be one important reason of Rictor upregulation and mTORC2 over-activation in glioma cells. Further, miR-153-induced anti-glioma cell activity is possibly via downregulating Rictor.

Highlights

  • glioma tissues (Glioma) causes large mortality around the world each year [1,2,3]

  • These results suggest that miR-153 downregulation could be one important reason of Rictor upregulation and mTOR complex 2 (mTORC2) over-activation in glioma cells

  • Mammalian target of rapamycin signaling is often dysregulated and hyper-activated in glioma, which mediates tumorigenesis, progression and chemoresistance [7,8,9]. mTOR lies in two distinct multi-protein mTOR complexes, including the traditional mTOR complex 1 and later-discovered rapamycin-insensitive mTOR complex 2 [10,11]. mTORC2 is composed of mTOR, Rictor, mSIN1, PLOS ONE | DOI:10.1371/journal.pone

Read more

Summary

Introduction

Glioma causes large mortality around the world each year [1,2,3]. The prognosis for highgrade glioma (grade III-IV) has been poor [1,2,3]. Existing evidences have demonstrated that Rictor overexpression and mTORC2 over-activation promote glioma cell migration and proliferation [14,15]. MiRNAs are capable of regulating gene expression at both translational and post-transcriptional levels [16,17]. These 19–24 nucleotide single-stranded noncoding RNAs silence targeted mRNAs through partial complementarity in their 30 untranslated regions (UTRs) [16,17]. We identified a potential anti-Rictor miRNA: microRNA-153 (miR-153). Our results suggest that miR-153 downregulation could be the reason of Rictor upregulation and mTORC2 over-activation in human glioma cells. Overexpression of miR-153-induced anti-glioma cell activity is possibly via downregulating Rictor

Reagents and antibodies
Culture of human primary astrocytes
Human glioma tissues
MTT assay of cell growth
Clonogenicity assay of cell growth
Western blotting
RNA extraction and real-time PCR
2.11. Rictor shRNA knockdown and stable cell selection
2.12. Xenograft assay
2.13. Statistical analysis
Rictor is a target of miR-153 in glioma cells
The anti-glioma activity by miR-153 in vivo
Discussions
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call